This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Exosomes Europe
4-5 November 2026
Hotel Palace BerlinBerlin, Germany
Book Now
Menu
Book
Key Sessions
Steffen Goletz, PhD
KEYNOTE: Novel platform of glycoengineered sEV for superior drug delivery and gene therapy
Danish Technical University
Shiran Shapira
[Clinical Case Study] Targeted by Nature, Powered by Innovation: EXO-CD24 Is Pioneering a New Class of Exosome-Based Therapies
Nano24
keyboard_arrow_right

Day 1 - Exosomes Europe

search
Day 1 - Exosomes Europe
search
Showing 1 of 1 Streams
08:30 - 09:00
Registration & Coffee
Opening Keynote
Showing 1 of 1 Streams
09:00 - 09:30
KEYNOTE: Novel platform of glycoengineered sEV for superior drug delivery and gene therapy
  • Steffen Goletz, PhD - Full Professor, Head of Biotherapeutic Glycoengineering and Immunology - Institute for Biotechnology & Biomedicine, Danish Technical University
Upstream Engineering & Precision Targeting
Showing 1 of 1 Streams
09:30 - 10:00
Cell Line Engineering: Optimising HEK vs. MSC Hubs
  • Bernd Giebel - Professor for Translational Extracellular Vesicle Research at University Hospital Essen and Co-Founder & CSO, Exosla Therapeutics
10:00 - 10:30
[Clinical Case Study] Targeted by Nature, Powered by Innovation: EXO-CD24 Is Pioneering a New Class of Exosome-Based Therapies
  • Shiran Shapira - CTO/CSO, Nano24
Showing 1 of 1 Streams
10:30 - 11:15
Morning Networking Break
Cargo Loading & New Frontiers
Showing 1 of 1 Streams
11:15 - 11:45
From Bioengineering to Scalable Manufacturing: Advancing Extracellular Vesicles for Targeted Therapeutic Applications
  • Madhusudhan Reddy Bobbili - Universitätsassistent (Assistant Professor), BOKU University
11:45 - 12:15
APN-EV: Stabilising the Functional Form of Adiponectin on Engineered Extracellular Vesicles for Metabolic Disease Therapy
  • Robert Mamoun - CEO, Ciloa
12:15 - 12:45
Scientific Track Presentation: Cargo Loading & New Frontiers
Showing 1 of 1 Streams
12:45 - 14:00
Networking Lunch in Exhibit Hall
Analytical Precision & Potency Assays
Showing 1 of 1 Streams
14:00 - 14:30
Analytical Markers: Distinguishing Natural from Manufactured
14:30 - 15:00
Potency Assay Development: Linking Cargo to Efficiency
15:00 - 15:30
Scientific Track Presentation: Analytical Precision & Potency Assays
Showing 1 of 1 Streams
15:30 - 16:15
Afternoon Networking Break
Regulatory CMC & Standardization Frameworks
Showing 1 of 1 Streams
16:15 - 16:45
Managing Bioreactor Dynamics: Mitigating Shear Sensitivity in EV Production
  • Lior Shaltiel - CEO, NurExone Biologic
16:45 - 17:15
PANEL DISCUSSION: Standardization Crisis: Harmonising Global Protocols
  • Implementing MISEV 2023 guidelines for counting and characterizing exosome products
  • Overcoming heterogeneity through standardised method adoption
  • Establishing universal methods for defining what constitutes an "exosome" versus other EVs.
  • Improving clinical data sharing to close knowledge gaps.
Showing 1 of 1 Streams
17:15 - 18:30
Drinks & Networking Reception
NextDay 2 - Exosomes Europe
Choose Day